Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

Results 1-10 of 21 (Search time: 0.001 seconds).
Item hits:
First PublishedTitleAuthor(s)Type
Jul-2012Effectiveness of interventions for reducing diabetes and cardiovascular disease risk in people with metabolic syndrome: systematic review and mixed treatment comparison meta-analysis.Dunkley, AJ; Charles, K; Gray, LJ; Camosso-Stefinovic, J; Davies, MJ; Khunti, KJournal Article
Aug-2007Glargine versus NPH insulin: efficacy in comparison with insulin aspart in a basal bolus regimen in type 1 diabetes--the glargine and aspart study (GLASS) a randomised cross-over study.Chatterjee, S; Jarvis-Kay, J; Rengarajan, T; Lawrence, IG; McNally, PG; Davies, MJJournal Article
Feb-2010Searching for the right outcome? A systematic review and meta-analysis of controlled trials using carotid intima-media thickness or pulse wave velocity to infer antiatherogenic properties of thiazolidinediones.Webb, DR; Davies, MJ; Gray, LJ; Abrams, KR; Srinivasan, B; Das, S; Taub, N; Lawrence, I; Sutton, S; Khunti, KJournal Article
Aug-2010Effect of insulin glargine on glycaemic control and weight in obese and non-obese people with type 2 diabetes: data from the AT.LANTUS trial.Khunti, K; Srinivasan, BT; Shutler, S; Davies, MJJournal Article
May-2004Prevention of Type 2 diabetes mellitus. A review of the evidence and its application in a UK setting.Davies, MJ; Tringham, JR; Troughton, J; Khunti, KKJournal Article
Nov-2011An update on exenatide, a novel therapeutic option for patients with type 2 diabetes.Crasto, W; Khunti, K; Davies, MJJournal Article
Aug-2008Insulin glargine and its role in glycaemic management of Type 2 diabetes.Elrishi, MA; Jarvis, J; Khunti, K; Davies, MJJournal Article
Jan-2005Post-prandial hyperglycaemia and prevention of cardiovascular disease.Davies, MJJournal Article
Oct-2008Recent advances in the management of type 2 diabetes mellitus: a review.Srinivasan, BT; Jarvis, J; Khunti, K; Davies, MJJournal Article
Aug-2008Reduced weight gain with insulin detemir compared to NPH insulin is not explained by a reduction in hypoglycemia.Davies, MJ; Derezinski, T; Pedersen, CB; Clauson, PJournal Article